Etoposide

asparaginase and isoaspartyl peptidase 1 ; Homo sapiens







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35525474 Co-encapsulation of l-asparaginase and etoposide in dextran nanoparticles for synergistic effect in chronic myeloid leukemia cells. 2022 Jun 25 2
2 32183896 Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report. 2020 Mar 17 1
3 24468315 Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma. 2014 Jan 1
4 24923454 Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients. 2014 Nov 1
5 23768637 Epstein-Barr virus-associated natural killer/T-cell lymphomas. 2013 Mar 1
6 22639106 NK/T-cell lymphomas: pathobiology, prognosis and treatment paradigm. 2012 Oct 1
7 23189085 Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia. 2012 1
8 12731672 Induction of complete remission of hypoplastic leukemia with antithymocyte globulin. 2003 Apr 1
9 10025887 Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: a report from the Taiwan Pediatric Oncology Group. 1999 Feb 1
10 1537631 Pre-treatment of a human T-lymphoblastoid cell line with L-asparaginase reduces etoposide-induced DNA strand breakage and cytotoxicity. 1992 Feb 20 6